SG11201708627TA - Bromodomain inhibitor - Google Patents
Bromodomain inhibitorInfo
- Publication number
- SG11201708627TA SG11201708627TA SG11201708627TA SG11201708627TA SG11201708627TA SG 11201708627T A SG11201708627T A SG 11201708627TA SG 11201708627T A SG11201708627T A SG 11201708627TA SG 11201708627T A SG11201708627T A SG 11201708627TA SG 11201708627T A SG11201708627T A SG 11201708627TA
- Authority
- SG
- Singapore
- Prior art keywords
- bromodomain inhibitor
- bromodomain
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151205P | 2015-04-22 | 2015-04-22 | |
| PCT/US2016/029029 WO2016172618A1 (en) | 2015-04-22 | 2016-04-22 | Bromodomain inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201708627TA true SG11201708627TA (en) | 2017-11-29 |
Family
ID=57143581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201708627TA SG11201708627TA (en) | 2015-04-22 | 2016-04-22 | Bromodomain inhibitor |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20160310423A1 (en) |
| EP (1) | EP3285770A4 (en) |
| JP (1) | JP2018513863A (en) |
| KR (1) | KR20170139119A (en) |
| CN (1) | CN107613981A (en) |
| AR (1) | AR104340A1 (en) |
| AU (1) | AU2016252992A1 (en) |
| BR (1) | BR112017022691A2 (en) |
| CA (1) | CA2983446C (en) |
| CL (1) | CL2017002679A1 (en) |
| CO (1) | CO2017011482A2 (en) |
| EA (1) | EA201792317A1 (en) |
| EC (1) | ECSP17071545A (en) |
| HK (1) | HK1243948A1 (en) |
| IL (1) | IL255120B (en) |
| MX (2) | MX2020010899A (en) |
| NZ (1) | NZ736630A (en) |
| PE (1) | PE20180036A1 (en) |
| PH (1) | PH12017501933A1 (en) |
| SG (1) | SG11201708627TA (en) |
| TW (1) | TW201642860A (en) |
| WO (1) | WO2016172618A1 (en) |
| ZA (1) | ZA201707186B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR104259A1 (en) | 2015-04-15 | 2017-07-05 | Celgene Quanticel Res Inc | BROMODOMINUM INHIBITORS |
| GB201506872D0 (en) | 2015-04-22 | 2015-06-03 | Ge Oil & Gas Uk Ltd | Novel compounds |
| US10702517B2 (en) | 2015-04-22 | 2020-07-07 | Celgene Quanticel Research, Inc. | Bromodomain inhibitor |
| US10150754B2 (en) | 2016-04-19 | 2018-12-11 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| JP7129973B2 (en) * | 2016-10-20 | 2022-09-02 | セルジーン クオンティセル リサーチ，インク． | Bromodomain inhibitor |
| JP7171557B2 (en) | 2016-10-27 | 2022-11-15 | セルジーン クオンティセル リサーチ，インク． | Combination pharmaceuticals containing bromodomains and extra-terminal protein inhibitors |
| CA3107050A1 (en) * | 2018-07-23 | 2020-01-30 | Celgene Quanticel Research, Inc. | Process for the preparation of bromodomain inhibitor |
| JP2024507232A (en) * | 2021-02-22 | 2024-02-16 | セルジーン・クオンティセル・リサーチ・インコーポレイテッド | Bromodomain (BET) inhibitors used to treat prostate cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| GB0919434D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| WO2013097052A1 (en) * | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| FI3640241T3 (en) * | 2013-10-18 | 2023-01-13 | Bromodomain inhibitors | |
| JP7129973B2 (en) * | 2016-10-20 | 2022-09-02 | セルジーン クオンティセル リサーチ，インク． | Bromodomain inhibitor |
-
2016
- 2016-04-19 TW TW105112168A patent/TW201642860A/en unknown
- 2016-04-21 AR ARP160101100A patent/AR104340A1/en unknown
- 2016-04-22 SG SG11201708627TA patent/SG11201708627TA/en unknown
- 2016-04-22 CN CN201680032770.1A patent/CN107613981A/en active Pending
- 2016-04-22 NZ NZ736630A patent/NZ736630A/en unknown
- 2016-04-22 MX MX2020010899A patent/MX2020010899A/en unknown
- 2016-04-22 CA CA2983446A patent/CA2983446C/en active Active
- 2016-04-22 KR KR1020177033575A patent/KR20170139119A/en not_active Application Discontinuation
- 2016-04-22 EA EA201792317A patent/EA201792317A1/en unknown
- 2016-04-22 EP EP16784024.8A patent/EP3285770A4/en not_active Withdrawn
- 2016-04-22 JP JP2017554566A patent/JP2018513863A/en active Pending
- 2016-04-22 AU AU2016252992A patent/AU2016252992A1/en not_active Abandoned
- 2016-04-22 PE PE2017002306A patent/PE20180036A1/en not_active Application Discontinuation
- 2016-04-22 MX MX2017013501A patent/MX2017013501A/en active IP Right Grant
- 2016-04-22 BR BR112017022691-0A patent/BR112017022691A2/en not_active Application Discontinuation
- 2016-04-22 WO PCT/US2016/029029 patent/WO2016172618A1/en active Application Filing
- 2016-04-22 US US15/136,761 patent/US20160310423A1/en not_active Abandoned
-
2017
- 2017-10-18 IL IL255120A patent/IL255120B/en active IP Right Grant
- 2017-10-20 CL CL2017002679A patent/CL2017002679A1/en unknown
- 2017-10-23 ZA ZA2017/07186A patent/ZA201707186B/en unknown
- 2017-10-23 PH PH12017501933A patent/PH12017501933A1/en unknown
- 2017-10-26 EC ECIEPI201771545A patent/ECSP17071545A/en unknown
- 2017-11-08 CO CONC2017/0011482A patent/CO2017011482A2/en unknown
-
2018
- 2018-03-14 HK HK18103550.6A patent/HK1243948A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017022691A2 (en) | 2018-07-17 |
| US20160310423A1 (en) | 2016-10-27 |
| TW201642860A (en) | 2016-12-16 |
| IL255120B (en) | 2021-03-25 |
| EP3285770A4 (en) | 2018-10-31 |
| AU2016252992A1 (en) | 2017-11-09 |
| HK1243948A1 (en) | 2018-07-27 |
| EP3285770A1 (en) | 2018-02-28 |
| JP2018513863A (en) | 2018-05-31 |
| NZ736630A (en) | 2024-03-22 |
| ZA201707186B (en) | 2019-01-30 |
| PH12017501933A1 (en) | 2018-03-19 |
| AR104340A1 (en) | 2017-07-12 |
| EA201792317A1 (en) | 2018-03-30 |
| CN107613981A (en) | 2018-01-19 |
| CO2017011482A2 (en) | 2018-01-31 |
| CA2983446A1 (en) | 2016-10-27 |
| PE20180036A1 (en) | 2018-01-09 |
| IL255120A0 (en) | 2017-12-31 |
| CL2017002679A1 (en) | 2018-05-25 |
| MX2017013501A (en) | 2018-02-09 |
| WO2016172618A1 (en) | 2016-10-27 |
| KR20170139119A (en) | 2017-12-18 |
| MX2020010899A (en) | 2022-02-15 |
| ECSP17071545A (en) | 2017-12-01 |
| CA2983446C (en) | 2024-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243326A1 (en) | Bromodomain inhibitors | |
| ME03759B (en) | Bromodomain inhibitors | |
| DK3256579T3 (en) | Cysteinprotease | |
| HK1243415A1 (en) | Bromodomain inhibitors | |
| DK3250592T3 (en) | Anti-transthyretin-antistoffer | |
| HK1243948A1 (en) | Bromodomain inhibitor | |
| IL265139B (en) | Dopamine-b-hydroxylase inhibitors | |
| GB201513481D0 (en) | Inhibitor compounds | |
| GB201505658D0 (en) | Inhibitor compounds | |
| GB201517368D0 (en) | Value | |
| GB201612860D0 (en) | Inhibitors | |
| GB201501004D0 (en) | Inhibitors | |
| DK3250312T3 (en) | Urea-metalnitrat-scr-system | |
| GB201511951D0 (en) | An eyeguard | |
| DK3242882T3 (en) | Cgrp-antagonistpeptider | |
| GB201520949D0 (en) | Inhibitors | |
| ZA201807614B (en) | Bromodomain inhibitors | |
| IL258458B (en) | Peroxyhemiacetal profragrant and proflavor compounds | |
| AU5516P (en) | LEP08 Lepidosperma squamatum | |
| AU5511P (en) | PTK647 Epichloe coenophiala | |
| GB201522453D0 (en) | Inhibitor compounds | |
| AU366552S (en) | Nutblock | |
| AU367131S (en) | USB-charger | |
| GB201516350D0 (en) | Anywhere bankstick | |
| GB201516257D0 (en) | Setouting application |